Pharma Pulse 2/17/25: What RFK Jr.'s New Power Means, Expected Developments in Industry LLM Application & more

Expected Developments in Industry LLM Application

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI ponders the next big developments and breakthroughs he expects to see in the application of large language models.

Maternal HIV Status Impacts Infant Size, Study Shows

Positive HIV status as well as socioeconomic disadvantages, not breastfeeding, are associated with infant length and birth weight, according to the results of a new South African study.

What RFK Jr.'s New Power Means for Vaccines, Weight-Loss Shots and Drug Ads

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Nexus Pharmaceuticals Receives FDA Approval for Tacrolimus Injection

Nexus Pharmaceuticals, LLC announces the U.S Food and Drug Administration (FDA) approval of Tacrolimus Injection 5 mg/mL. Nexus’ Tacrolimus Injection is the first and only vial that will be available.

Pharmaceutical Commerce Magazine on LinkedIn

🚨Our February issue is LIVE🚨
This month we're covering #3PLs▪️#pharmacydeserts▪️ PLUS the debut of two NEW columns focused on #patientsupport and #brandprotection▪️All that and more, right here ➡️ https://lnkd.in/eWQt9eDJ

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs